The diversified healthcare group reported quarterly earnings before interests and taxes, and before special items, of 634 million euros ($685 million), 7% above analysts' expectations of 591 million in a poll compiled by Vara Research. The company's strong result echoes the performance of its former dialysis unit Fresenius Medical Care, which on Tuesday reported upbeat quarterly results and gave a higher 2024 guidance. Fresenius CEO Michael Sen, who took the helm a year ago, has been restructuring the group to cut costs and debt, after it was hit by a decline in earnings at FMC.
The diversified healthcare group reported quarterly earnings before interests and taxes, and before special items, of 634 million euros ($685 million), 7% above analysts' expectations of 591 million in a poll compiled by Vara Research. The company's strong result echoes the performance of its former dialysis unit Fresenius Medical Care, which on Tuesday reported upbeat quarterly results and gave a higher 2024 guidance. Fresenius CEO Michael Sen, who took the helm a year ago, has been restructuri